Future jobs of FDA’s haematology-oncology reviewers

Medical reviewers at the US Food and Drug Administration are vital to effective regulation, interpreting whether a drug’s harm-benefit balance is favourable. When regulators leave government, some work or consult for the industries they regulated.1 2 Although this “revolving door” has been criticised,1 2 it has not been studied. We sought to measure how often it occurs at the FDA.

Using the set of FDA haematology-oncology drug approvals listed on its …